David Bajor, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Case Western Reserve University School of Medicine
Medical School
University of Pennsylvania Health System
Residency
University of Pennsylvania Health System
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
PA State Medical License Active through 2016
OH State Medical License Active through 2017
Hospital of the University of Pennsylvania
Languages: English/Spanish
(215) 662-4000
3400 Spruce St
Philadelphia, Pennsylvania 19104
Lack of immunoediting in murine pancreatic cancer reversed with neoantigen.
Evans RA, Diamond MS, Rech AJ, Chao T, Richardson MW, Lin JH, Bajor DL, Byrne KT, Stanger BZ, Riley JL, Markosyan N, Winograd R, Vonderheide RH; JCI Insight. 2016-09-08.
See more >>Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma.
Winograd, R.,Byrne, K. T.,Evans, R. A.,Odorizzi, P. M.,Meyer, A. R.,Bajor, D. L.,Clendenin, C.,Stanger, B. Z.,Furth, E. E.,Wherry, E. J.,Vonderheide, R. H.; Cancer Immunol Res. 2015 Feb 14.
See more >>Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma.
Bajor, D. L.,Xu, X.,Torigian, D. A.,Mick, R.,Garcia, L. R.,Richman, L. P.,Desmarais, C.,Nathanson, K. L.,Schuchter, L. M.,Kalos, M.,Vonderheide, R. H.; Cancer Immunol Res. 2014 Sep 26.
See more >>